DYN FY 2009 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.5B-30.5% YoY

Gross Profit

$1.3B51.6% margin

Operating Income

-$834M-33.8% margin

Net Income

-$1.3B-51.1% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

$135M

Free Cash Flow

$135M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$8.0B

Stockholders' Equity

$2.9B

Cash & Equivalents

$471M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$3.5B	-30.5%
Gross Profit	$1.3B	$1.7B	-24.9%
Operating Income	-$834M	$709M	-217.6%
Net Income	-$1.3B	$174M	-825.3%